B. Braun Medical Inc. recalled 74,088 containers of Lactated Ringer's Injection on August 4, 2025. The recall stems from a lack of assurance of sterility and potential fluid leakage. Consumers and healthcare providers should discontinue use immediately and seek guidance.
Lack of Assurance of Sterility; potential for fluid leakage at one of the weld sites.
Consumers and healthcare providers should stop using this product immediately. Contact B BRAUN MEDICAL INC or your healthcare provider for guidance. Notification method: Letter
The recall affects Lactated Ringer's Injection USP, L 7500, 1000mL Excel Container, Rx Only. The affected lot numbers include J5C802, J5C917, and J5C918, with an expiration date of August 31, 2027.
The product poses a high risk due to the lack of assurance of sterility. There is also a potential for fluid leakage at one of the weld sites.
No specific incidents or injuries related to this recall have been reported, but the potential risks warrant immediate action.
Stop using the product immediately. Contact B. Braun Medical Inc. or your healthcare provider for further guidance.
For more information, visit the FDA website at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0585-2025.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.